OvaRenew as a first-line therapy in impaired egg quality treatment

Project Information

OvaRenew

Grant agreement ID: 743905

DOI 10.3030/743905

Closed project

EC signature date 15 November 2016

Start date 1 December 2016

End date 31 May 2017

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

POTENZA MEDICA D.O.O.
Slovenia